Anticholinergic agents, such as benztropine (Cogentin) or diphenhydramine (Benadryl), may be given with a typical antipsychotic, such as fluphenazine (Prolixin) to:

Lithium is a narrow therapeutic index medication commonly used for bipolar disorder to stabilize mood and prevent manic and depressive episodes. Because the difference between therapeutic and toxic levels is small, patients require careful monitoring of serum levels, renal function, and clinical symptoms. Toxicity can develop gradually or suddenly and may be triggered by dehydration, drug interactions, or impaired renal clearance. Early recognition of toxicity signs is critical to prevent serious neurologic and systemic complications.

Rationale:
A. A new or worsening tremor is an early sign of lithium toxicity. With Lithium, mild fine tremors may occur at therapeutic levels, but progression to coarse tremors suggests increasing serum concentration and potential toxicity. This symptom reflects early neuromuscular involvement and requires prompt evaluation of serum lithium levels.

B. Nausea and vomiting are common gastrointestinal manifestations of lithium toxicity. As serum levels of Lithium rise, GI irritation occurs early and may precede more severe neurologic symptoms. These symptoms should not be dismissed as routine side effects when they are persistent or worsening.

C. Confusion is a serious neurologic sign of lithium toxicity indicating central nervous system involvement. Elevated levels of Lithium can impair cognitive function, leading to disorientation, lethargy, and in severe cases, seizures or coma. This is a late and potentially life-threatening manifestation requiring urgent intervention.

D. All options are correct because tremor, nausea/vomiting, and confusion are all recognized clinical signs of lithium toxicity. With Lithium, toxicity affects multiple body systems including gastrointestinal, neurologic, and neuromuscular systems. Recognizing the full spectrum of symptoms is essential for early detection and prevention of severe complications.

Anticonvulsant medications are used to manage seizure disorders by stabilizing neuronal activity in the central nervous system. Some antiepileptic drugs require routine serum level monitoring due to narrow therapeutic ranges, nonlinear pharmacokinetics, or significant toxicity risk at elevated levels. Others have more predictable dosing and pharmacokinetics, making routine therapeutic drug monitoring unnecessary in most clinical settings. Understanding which drugs require monitoring helps ensure safe and effective seizure control.

Rationale:
A. Phenytoin (Dilantin) requires routine therapeutic drug monitoring because it has nonlinear (zero-order) kinetics and a narrow therapeutic index. Small dose changes can lead to disproportionate increases in serum levels, increasing the risk of toxicity such as nystagmus, ataxia, and CNS depression. Monitoring helps maintain levels within the therapeutic range and avoid adverse effects.

B. Valproic acid (Depakote) often requires serum level monitoring due to its variable metabolism and potential for hepatotoxicity and thrombocytopenia. Monitoring ensures therapeutic efficacy while minimizing toxicity, especially in vulnerable populations such as children and patients with liver disease. Drug levels help guide dose adjustments when clinical response is unclear.

C. Carbamazepine (Tegretol) requires routine monitoring because it induces its own metabolism (autoinduction) and has a narrow therapeutic window. Serum levels are used to ensure adequate seizure control while avoiding toxicity such as diplopia, dizziness, and bone marrow suppression. Regular monitoring is essential during dose initiation and adjustments.

D. Lamotrigine (Lamictal) does not routinely require therapeutic drug level monitoring because it has more predictable pharmacokinetics and a wider therapeutic index compared to other anticonvulsants. Dosing is typically guided by clinical response rather than serum levels. Monitoring is primarily focused on clinical assessment, especially for serious adverse effects such as rash or Stevens-Johnson syndrome rather than routine blood level checks.